Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 5 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

4Total

Not Applicable (4)

Trial Status

Completed3

Recruiting2

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 3 completed trials

Clinical Trials (5)

Showing 5 of 5 trials

NCT07852936Not ApplicableRecruiting

Group-based Emotional Awareness and Expression Therapy to Support Recovery After Acquired Brain Injury: A Clinical Development and Evaluation Study

NCT04437498Not ApplicableRecruiting

Vagal Nerve Stimulation in mTBI

NCT03836976Not ApplicableCompletedPrimary

Detection and Amelioration of Gamma Oscillation Abnormalities in Blast-Related Brain Injury

NCT04195685Not ApplicableCompleted

Neurofeedback Impact on Veterans With mTBI

NCT01661075CompletedPrimary

Quantification of Balance in Acutely Concussed Athletes

Showing all 5 trials

mTBI